Polymorphisms of human nonmetastatic clone 23 type 1 gene and neoplastic lesions of uterine cervix

Reproductive Sciences

Volumn 17, Issue 10, 2010, Pages 886-893

  Feng, Chi Yen ^a   Wang, Po Hui ^b,c   Tsai, Hsiu Ting ^b,c   Tee, Yi Torng ^b,c   Ko, Jiunn Liang ^b   Chen, Shiuan Chih ^b,c   Lin, Ching Yi ^b,c   Han, Chih Ping ^b,c   Yang, Jia Sin ^b   Liu, Yu Fan ^b   Lin, Long Yau ^b,c   Yang, Shun Fa ^b,c  

^a Da Chien General Hospital   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

heterozygote; homozygote; human nonmetastatic clone 23 type 1 gene; neoplasia of uterine cervix; single nucleotide polymorphisms

Indexed keywords

ADULT; ARTICLE; BLOOD SAMPLING; CLONE 23 TYPE 1 GENE; CONTROLLED STUDY; FEMALE; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TAIWAN; TUMOR GENE; UTERINE CERVIX TUMOR;

CHI-SQUARE DISTRIBUTION; DNA, NEOPLASM; FEMALE; GENETIC VARIATION; GENOTYPE; HUMANS; MIDDLE AGED; NM23 NUCLEOSIDE DIPHOSPHATE KINASES; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; TAIWAN; UTERINE CERVICAL NEOPLASMS;

EID: 77956652260     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719110373661     Document Type: Article

References (32)

1. Steeg PS, Bevilacqua G., Pozzatti R., Liotta LA, Sobel ME Altered expression of NM23, a gene associated with low tumor metastatic potential, during adenovirus 2 Ela inhibition of experimental metastasis. Cancer Res. 1988 ; 48 (22). 6550-6554.
2. Rosengard AM, Krutzsch HC, Shearn A., et al. Reduced Nm23/ Awd protein in tumour metastasis and aberrant Drosophila development. Nature. 1989 ; 342 (6246). 177-180.
3. Lacombe ML, Milon L., Munier A., Mehus JG, Lambeth DO The human Nm23/nucleoside diphosphate kinases. J Bioenerg Biomembr. 2000 ; 32 (3). 247-258.
4. Ouatas T., Salerno M., Palmieri D., Steeg PS Basic and translational advances in cancer metastasis: Nm23. J Bioenerg Biomembr. 2003 ; 35 (1). 73-79.
5. Crawford RM, Treharne KJ, Best OG, Muimo R., Riemen CE, Mehta A. A novel physical and functional association between nucleoside diphosphate kinase A and AMP-activated protein kinase alpha1 in liver and lung. Biochem J. 2005 ; 392 (pt 1). 201-209.
6. Sirotkovic-Skerlev M., Krizanac S., Kapitanovic S., Husnjak K., Unusic J., Pavelic K. Expression of c-myc, erbB-2, p53 and nm23-H1 gene product in benign and malignant breast lesions: coexpression and correlation with clinicopathologic parameters. Exp Mol Pathol. 2005 ; 79 (1). 42-50.
7. Kapitanovic S., Cacev T., Berkovic M., et al. nm23-H1 expression and loss of heterozygosity in colon adenocarcinoma. J Clin Pathol. 2004 ; 57 (12). 1312-1318.
8. Tomic S., Ilic Forko J., Babic D., Sundov D., Kuret S., Andelinovic S. c-erbB-2, p53, and nm23 proteins as prognostic factors in patients with epithelial ovarian carcinoma. Croat Med J. 2003 ; 44 (4). 429-434.
9. Hsu CG, Lin LY, Ko JL, et al. High expression of human nonmetastatic clone 23 type 1 in cancer of uterine cervix and its association with poor cell differentiation and worse overall survival. J Surg Oncol. 2008 ; 98 (6). 448-456.
10. Boissan M., Wendum D., Arnaud-Dabernat S., et al. Increased lung metastasis in transgenic NM23-Null/SV40 mice with hepatocellular carcinoma. J Natl Cancer Inst. 2005 ; 97 (11). 836-845.
11. Ostör AG Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol. 1993 ; 12 (2). 186-192.
12. Holowaty P., Miller AB, Rohan T., To T. Natural history of dysplasia of the uterine cervix. J Natl Cancer Inst. 1999 ; 91 (3). 252-258.
13. Moscicki AB, Hills N., Shiboski S., et al. Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females. JAMA. 2001 ; 285 (23). 2995-3002.
14. Cox JT Evaluation of abnormal cervical cytology. Clin Lab Med. 2000 ; 20 (2). 303-343.
15. Tay SK, Ngan HY, Chu TY, Cheung AN, Tay EH Epidemiology of human papillomavirus infection and cervical cancer and future perspectives in Hong Kong, Singapore and Taiwan. Vaccine. 2008 ; 26 (12). M60 - M70.
16. Pagliusi SR, Teresa Aguado M. Efficacy and other milestones for human papillomavirus vaccine introduction. Vaccine. 2004 ; 23 (5). 569-578.
17. Schiffman M., Kjaer SK Chapter 2: natural history of anogenital human hapillomavirus infection and neoplasia. J Natl Cancer Inst Monogr. 2003 ; 31: 14-19.
18. Kiviat N. Natural history of cervical neoplasia: overview and update. Am J Obstet Gynecol. 1996 ; 175 (4 pt 2). 1099-1104.
19. Woodman CB, Collins S., Winter H., et al. Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study. Lancet. 2001 ; 357 (9271). 1831-1836.
20. Wang PH, Chang H., Ko JL, Lin LY Nm23-H1 immunohistochemical expression in multisteps of cervical carcinogenesis. Int J Gynecol Cancer. 2003 ; 13 (3). 325-330.
21. Wang PH, Ko JL, Chang H., Lin LY Clinical significance of high nm23-H1 expression in intraepithelial neoplasia and early-stage squamous cell carcinoma of the uterine cervix. Gynecol Obstet Invest. 2003 ; 55 (1). 14-19.
22. Ravazoula P., Aletra C., Kourounis G., Ladopoulos I., Tzigounis V. Immunohistochemical analysis of nm23-H1 expression in human cervical lesions. Eur J Gynaecol Oncol. 2000 ; 21 (5). 510-512.
23. Zhang L., Zhou W., Velculescu VE, et al. Gene expression profiles in normal and cancer cells. Science. 1997 ; 276 (5316). 1268-1272.
24. Hsu CG, Wang PH, Ko JL, et al. Concurrent high expression of human telomerase reverse transcriptase and human nonmetastatic clone 23 in high-grade squamous intraepithelial neoplasia and squamous cell carcinoma of uterine cervix. Int J Gynecol Cancer. 2007 ; 17 (4). 851-857.
25. Yague J., Juan M., Leone A., et al. BglII and EcoRI polymorphism of the human nm23-H1 gene (NME1). Nucleic Acids Res. 1991 ; 19 (23). 6663.
26. Qu S., Long J., Cai Q., et al. Genetic polymorphisms of metastasis suppressor gene NME1 and breast cancer survival. Clin Cancer Res. 2008 ; 14 (15). 4787-4793.
27. Steeg PS Tumor metastasis: mechanistic insights and clinical challenges. Nat Med. 2006 ; 12 (8). 895-904.
28. Chen HY, Hsu CT, Lin WC, Tsai HD, Chang WC Prognostic value of nm23 expression in stage IB1 cervical carcinoma. Jpn J Clin Oncol. 2001 ; 31 (7). 327-332.
29. Rubio SA, Martinez SE, Corona JS, et al. EcoRI polymorphism of the metastasis-suppressor gene NME1 in Mexican patients with breast cancer. Breast Cancer Res Treat. 2006 ; 96 (2). 159-161.
30. Choudhuri T., Verma SC, Lan K., Robertson ES Expression of alpha V integrin is modulated by Epstein-Barr virus nuclear antigen 3C and the metastasis suppressor nm23-H1 through interaction with the GATA-1 and Sp1 transcription factors. Virology. 2006 ; 351 (1). 58-72.
31. Ouatas T., Clare SE, Hartsough MT, De La Rosa A., Steeg PS MMTV-associated transcription factor binding sites increase nm23-H1 metastasis suppressor gene expression in human breast carcinoma cell lines. Clin Exp Metastasis. 2002 ; 19 (1). 35-42.
32. Hsieh YS, Lee YL, Yang SF, et al. Association of EcoRI polymorphism of the metastasis-suppressor gene NME1 with susceptibility to and severity of non-small cell lung cancer. Lung Cancer. 2007 ; 58 (2). 191-195.